Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase NA 3Phase 1/2 3Phase 2/3 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Hyperthermia 2Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Rectal Neoplasms 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Diathermy × Clear all
NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown
59 enrolled
Gastrointestinal

Hyperthermia, Rectal Neoplasms

NCT01904565 2015-09-02

HYPROSAR

Kantonsspital Aarau

Phase 1/2 Unknown
26 enrolled
Sarcoma

Hyperthermia, Sarcoma

NCT00004063 2009-04-30

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡